about
Onset of psoriasis in patients with inflammatory bowel disease treated with anti-TNF agentsEndoscopic injection of cyanoacrylate glue versus other endoscopic procedures for acute bleeding gastric varices in people with portal hypertensionEpinephrine injection versus epinephrine injection and a second endoscopic method in high-risk bleeding ulcersOptimum duration of regimens for Helicobacter pylori eradicationSystematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitisOptimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistanceA genome-wide association study on a southern European population identifies a new Crohn's disease susceptibility locus at RBX1-EP300Multicentre evaluation of music perception in adult users of Advanced Bionics cochlear implants.[Immune-mediated inflammatory diseases in patients with inflammatory bowel disease. Baseline data from the Aquiles study].Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection.[Helicobacter pylori resistance to metronidazole and to clarithromycin in Spain. A systematic review]Severe adalimumab-induced thrombocytopenia in a patient with Crohn's disease.Ranitidine bismuth citrate therapy regimens for treatment of Helicobacter pylori infection: a review.Treatment of Helicobacter pylori infection 2011.[Current management of nonvariceal upper gastrointestinal bleeding in Spain].Improving pharmacovigilance in Europe: TPMT genotyping and phenotyping in the UK and SpainEpidemiology of inflammatory bowel disease in Spain. A systematic review.Second-line rescue therapy of helicobacter pylori infection.Helicobacter pylori infection and precancerous lesions of the stomach.Accuracy of GastroPanel for the diagnosis of atrophic gastritis.Helicobacter pylori and bleeding duodenal ulcer: prevalence of the infection and role of non-steroidal anti-inflammatory drugs.Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer.Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review.Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding.[Prevalence of Helicobacter pylori infection in gastric MALT lymphoma: a systematic review]Clinical patterns and outcomes of ischaemic colitis: results of the Working Group for the Study of Ischaemic Colitis in Spain (CIE study).Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis.Accuracy of computed tomographic colonography for the detection of polyps and colorectal tumors: a systematic review and meta-analysis.Review article: is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)?Helicobacter pylori and bleeding peptic ulcer: what is the prevalence of the infection in patients with this complication?Systematic review: Rabeprazole-based therapies in Helicobacter pylori eradication.Helicobacter pylori infection and perforated peptic ulcer prevalence of the infection and role of antimicrobial treatment.Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis.Effect of Infliximab in oxidised serum albumin levels during experimental colitis.Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis.Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori.Stool antigen test for the diagnosis of Helicobacter pylori infection: a systematic review.Current concepts on microscopic colitis: evidence-based statements and recommendations of the Spanish Microscopic Colitis Group.
P50
Q22305935-840C2687-BCDC-4F06-B2CC-F71982897A2EQ24187969-F1B110BD-9828-4174-B7AF-4D413A381BD8Q24193110-AF7BF776-9898-440A-AE07-B0941D2D0684Q24201841-68187290-BFCA-490E-A594-B7CD354A7D3EQ27011853-3CF240A5-3DC2-42A9-ACDC-A205FA83B6ACQ28288530-133E4D85-0689-4C0E-9B38-7817FE6E2EBAQ28943442-F6BA5C51-4AE7-4EB2-A11A-89558F95A95DQ30353977-15048248-CE3B-4C1E-A398-9313FC2D62F1Q30797477-901BCF5F-2DB1-4199-A84E-4F386DF7E8F0Q31154023-4A2D674F-25F9-4221-AE5F-F260C3AFA37DQ31955396-EC1BDC47-760D-4A8B-8CCF-89837716458EQ33400929-A3E9CE05-7B64-4531-9A25-8D84C9FAFA70Q33648702-ED0E88DF-EB0E-4855-938C-CD70177E4767Q34028419-15457943-48E0-4388-AEFA-7933DA1A91C9Q34250255-9280E061-1ABE-497E-923F-0573ED13C437Q34326911-42BDCA8F-E5F0-4836-BCA4-427BFBA6B175Q34327730-DC70B522-6791-4358-9833-4C3C2D4541F3Q34409114-807C7033-F2C2-440E-940A-81878AF13D55Q34507370-DB95BE34-7FD7-430B-97A8-A54C282DD7E8Q34512994-69EB72C5-3AC6-44D1-9FE3-C35A2601B7BEQ34516165-05531DDF-A363-49D6-A095-EE8C44070059Q34542021-6DAB2A72-A801-4313-AC9D-75397912290AQ34546364-D3717419-A37E-4F30-A3BC-8C93D321D68DQ34575542-89933A4F-5B81-4AB6-A2B9-FCCBF46453D6Q34581560-B3AD1284-AEAB-4673-BD59-A15E50992CAFQ34584401-E977A5B6-CC9D-480A-8A65-7B42729B0BE4Q34624525-BE5C39D7-7007-4C3E-A695-A909B4BF7986Q34657352-7B487CA2-E101-4098-9218-F1CA132B0ACCQ34657365-9AF3A88C-A2D7-415F-90C5-678C3D92E148Q34658454-D3505262-EC90-40B2-A783-02322CF22975Q35030826-A92D991D-C3EF-42BE-9099-973ACCF0EBEDQ35074139-7C48E021-6968-41D3-9DCC-71DD4A9DA26AQ35086840-C4562392-4CC7-46A6-A516-868EE4EAFA6EQ35129759-253F8E2A-DF56-4F3F-BDB9-0CD1E43C94F8Q35217843-D8B01B34-19F5-4D2E-9496-DC61599415B7Q35405853-5FB7A506-124C-4C59-B5FC-BE0D0CA27004Q35629704-1E1E8FAA-3C8B-4520-8F14-599B8C186EA9Q35841617-4AC6122C-1737-44B5-9F7B-7F50EC0E6F9FQ35843788-369A7355-469D-45AA-AA24-DD21FBAF586CQ35849043-E1BA5862-5D2E-4F63-AB97-489BFAE88C2D
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Javier P Gisbert
@ast
Javier P Gisbert
@en
Javier P Gisbert
@es
Javier P Gisbert
@nl
Javier P Gisbert
@sl
type
label
Javier P Gisbert
@ast
Javier P Gisbert
@en
Javier P Gisbert
@es
Javier P Gisbert
@nl
Javier P Gisbert
@sl
prefLabel
Javier P Gisbert
@ast
Javier P Gisbert
@en
Javier P Gisbert
@es
Javier P Gisbert
@nl
Javier P Gisbert
@sl
P106
P21
P31
P3835
javier-gisbert
P496
0000-0003-2090-3445